Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

BACKGROUND: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries. METHODS:...

Full description

Bibliographic Details
Published in:Neuro-Oncology
Main Authors: Kenborg, Line, Winther, Jeanette Falck, Linnet, Karen Markussen, Krøyer, Anja, Albieri, Vanna, Holmqvist, Anna Sällfors, Tryggvadottir, Laufey, Madanat-Harjuoja, Laura Maria, Stovall, Marilyn, Hasle, Henrik, Olsen, Jørgen H
Format: Text
Language:English
Published: Oxford University Press 2019
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/
http://www.ncbi.nlm.nih.gov/pubmed/29850875
https://doi.org/10.1093/neuonc/noy094
id ftpubmed:oai:pubmedcentral.nih.gov:6303468
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:6303468 2023-05-15T16:51:45+02:00 Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study Kenborg, Line Winther, Jeanette Falck Linnet, Karen Markussen Krøyer, Anja Albieri, Vanna Holmqvist, Anna Sällfors Tryggvadottir, Laufey Madanat-Harjuoja, Laura Maria Stovall, Marilyn Hasle, Henrik Olsen, Jørgen H 2019-01 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 https://doi.org/10.1093/neuonc/noy094 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/ http://www.ncbi.nlm.nih.gov/pubmed/29850875 http://dx.doi.org/10.1093/neuonc/noy094 © The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Pediatric Neuro-Oncology Text 2019 ftpubmed https://doi.org/10.1093/neuonc/noy094 2020-01-05T01:16:04Z BACKGROUND: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries. METHODS: We identified 4858 five-year survivors with diagnoses of CNS tumor in childhood in Denmark, Iceland, Finland, and Sweden in 1943–2007, and 166658 matched population comparison subjects. Inpatient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs). RESULTS: A neurologic disorder was verified in 1309 survivors, while 92.4 were expected, yielding an overall RR of 14.2 (95% confidence interval [CI]: 13.3–15.1) and an AER of 20 hospitalizations per 1000 persons per year. The risks remained increased more than 20 years after diagnosis (RR: 6.3, 95% CI: 5.6–7.2; AER: 11, 9–12). The most frequent diagnoses were epilepsy (affecting 14.1% of all survivors) followed by hydrocephalus (9.5%) and paralytic syndromes (4.2%), with RRs of 28.7 (95% CI: 26.0–31.6), 243 (95% CI: 190–311), and 40.3 (95% CI: 33.1–49.2), respectively. Of these outcomes, 30%–40% were diagnosed prior to or synchronously with the CNS tumor. The survivors had highly increased RRs for infectious diseases of the CNS, disorders of cranial nerves, and degenerative diseases of the nervous system. CONCLUSIONS: Survivors of childhood CNS tumors are at markedly increased risk for neurologic disorders throughout their lives. Health care professionals must be aware of survivors who might benefit from preventive interventions and intensive follow-up. Text Iceland PubMed Central (PMC) Neuro-Oncology 21 1 125 136
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Pediatric Neuro-Oncology
spellingShingle Pediatric Neuro-Oncology
Kenborg, Line
Winther, Jeanette Falck
Linnet, Karen Markussen
Krøyer, Anja
Albieri, Vanna
Holmqvist, Anna Sällfors
Tryggvadottir, Laufey
Madanat-Harjuoja, Laura Maria
Stovall, Marilyn
Hasle, Henrik
Olsen, Jørgen H
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
topic_facet Pediatric Neuro-Oncology
description BACKGROUND: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries. METHODS: We identified 4858 five-year survivors with diagnoses of CNS tumor in childhood in Denmark, Iceland, Finland, and Sweden in 1943–2007, and 166658 matched population comparison subjects. Inpatient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs). RESULTS: A neurologic disorder was verified in 1309 survivors, while 92.4 were expected, yielding an overall RR of 14.2 (95% confidence interval [CI]: 13.3–15.1) and an AER of 20 hospitalizations per 1000 persons per year. The risks remained increased more than 20 years after diagnosis (RR: 6.3, 95% CI: 5.6–7.2; AER: 11, 9–12). The most frequent diagnoses were epilepsy (affecting 14.1% of all survivors) followed by hydrocephalus (9.5%) and paralytic syndromes (4.2%), with RRs of 28.7 (95% CI: 26.0–31.6), 243 (95% CI: 190–311), and 40.3 (95% CI: 33.1–49.2), respectively. Of these outcomes, 30%–40% were diagnosed prior to or synchronously with the CNS tumor. The survivors had highly increased RRs for infectious diseases of the CNS, disorders of cranial nerves, and degenerative diseases of the nervous system. CONCLUSIONS: Survivors of childhood CNS tumors are at markedly increased risk for neurologic disorders throughout their lives. Health care professionals must be aware of survivors who might benefit from preventive interventions and intensive follow-up.
format Text
author Kenborg, Line
Winther, Jeanette Falck
Linnet, Karen Markussen
Krøyer, Anja
Albieri, Vanna
Holmqvist, Anna Sällfors
Tryggvadottir, Laufey
Madanat-Harjuoja, Laura Maria
Stovall, Marilyn
Hasle, Henrik
Olsen, Jørgen H
author_facet Kenborg, Line
Winther, Jeanette Falck
Linnet, Karen Markussen
Krøyer, Anja
Albieri, Vanna
Holmqvist, Anna Sällfors
Tryggvadottir, Laufey
Madanat-Harjuoja, Laura Maria
Stovall, Marilyn
Hasle, Henrik
Olsen, Jørgen H
author_sort Kenborg, Line
title Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
title_short Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
title_full Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
title_fullStr Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
title_full_unstemmed Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
title_sort neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an adult life after childhood cancer in scandinavia (aliccs) study
publisher Oxford University Press
publishDate 2019
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/
http://www.ncbi.nlm.nih.gov/pubmed/29850875
https://doi.org/10.1093/neuonc/noy094
genre Iceland
genre_facet Iceland
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303468/
http://www.ncbi.nlm.nih.gov/pubmed/29850875
http://dx.doi.org/10.1093/neuonc/noy094
op_rights © The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
op_doi https://doi.org/10.1093/neuonc/noy094
container_title Neuro-Oncology
container_volume 21
container_issue 1
container_start_page 125
op_container_end_page 136
_version_ 1766041849123831808